← FDA DRUG APPROVALS

FDA ANDA · ANDA076165

FLUOXETINE HYDROCHLORIDE

Sponsor: CR DOUBLE CRANE

APPLICATION
ANDA076165
TYPE
ANDA
ORIGINAL APPROVAL
2002-02-01
LATEST ACTION
2008-07-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FLUOXETINE HYDROCHLORIDEDiscontinued
FLUOXETINE HYDROCHLORIDE EQ 10MG BASE · CAPSULE · ORAL
FLUOXETINE HYDROCHLORIDEDiscontinued
FLUOXETINE HYDROCHLORIDE EQ 20MG BASE · CAPSULE · ORAL

Approval history

2008-07-07Labeling · Supplement 4AP
2007-10-24Labeling · Supplement 3AP
2006-10-05Labeling · Supplement 2AP
2002-02-01Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →